From: SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
Region of interest | PDNDYS(n= 27) | PDDYS(n= 23) | P value |
---|---|---|---|
Striatum, whole | 4.02 ± 0.30 | 4.16 ± 0.24 | 0.66 |
Striatum, most affected side | 3.43 ± 0.31 | 3.59 ± 0.27 | 0.57 |
Caudate nucleus, whole | 6.02 ± 0.30 | 6.33 ± 0.25 | 0.52 |
Caudate nucleus, most affected side | 5.34 ± 0.34 | 5.73 ± 0.28 | 0.43 |
Putamen, whole | 3.03 ± 0.32 | 3.00 ± 0.26 | 0.93 |
Putamen, most affected side | 2.39 ± 0.33 | 2.43 ± 0.28 | 0.82 |
Midbrain | 1.05 ± 0.40 | 1.14 ± 0.35 | 0.41 |
Midbrain/Putamen, whole | 0.33 ± 0.32 | 0.35 ± 0.36 | 0.48 |
Midbrain/Putamen most affected side | 0.42 ± 0.32 | 0.44 ± 0.38 | 0.67 |
Midbrain/Caudate, whole | 0.17 ± 0.32 | 0.17 ± 0.32 | 0.88 |
Midbrain/Caudate, most affected side | 0.19 ± 0.34 | 0.19 ± 0.37 | 0.97 |
Midbrain/Striatum, whole | 0.25 ± 0.31 | 0.26 ± 0.34 | 0.75 |
Midbrain/Striatum, most affected side | 0.29 ± 0.31 | 0.30 ± 0.38 | 0.87 |